Healthcare · head to head
Rx30 vs Techcyte

Rx30
Healthcare
Long-established pharmacy management system for independents and small chains
- From
- On request
- Rated
- -

Techcyte
Healthcare
AI digital pathology across clinical, veterinary and environmental laboratory disciplines
- From
- On request
- Rated
- -
The short version
- Each has a real cost: Rx30 shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally; Techcyte regulatory status runs the opposite way to what most buyers assume: the products are CE marked and clinically deployed in Europe while several United States offerings including Fusion Parasitology are labelled research use only and not for diagnostic use, so an American laboratory must verify each module individually.
- They diverge on capability: Rx30 covers Prescription processing, Techcyte covers Fusion Parasitology Suite.
- Prices and features above were last checked on 1 September 2026.
Where they differ
Only the attributes on which Rx30 and Techcyte actually diverge.
Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in Rx30
- Prescription processing
- Claims adjudication
- Inventory and purchasing
- Point of sale
- Delivery management
- Clinical documentation
Only in Techcyte
- Fusion Parasitology Suite
- Cervical cytology
- Haematology
- Urinalysis
- Bacteriology and mycology
- Vetcyte
- Scanner agnostic ingestion
- Remote review
What people use each for
The jobs each tool is most often brought in to do.
Rx30
- Independent pharmacies and small chains wanting a mature, widely-supported systemnot Techcyte
- Operations relying on a broad set of wholesaler and PBM interfacesnot Techcyte
- Pharmacies with significant front-end retail alongside dispensingnot Techcyte
- Multi-store independents needing consistency across locationsnot Techcyte
Techcyte
- A clinical laboratory that cannot recruit technologists for high volume manual parasitology screening and needs AI pre screening with human releasenot Rx30
- A veterinary reference laboratory processing large volumes of faecal and blood smears that wants Vetcyte to triage the normal casesnot Rx30
- A European laboratory that can deploy the CE marked products clinically, which is where Techcyte regulatory position is strongestnot Rx30
- An environmental testing laboratory needing consistent microscopy classification across analysts and sitesnot Rx30
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
Rx30
- Shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally
- The interface shows its age against newer entrants, and this is the most common objection in demonstrations
- Pricing is not published, and total cost including hardware and interfaces needs to be requested explicitly
- Windows-centric, with a cloud story less developed than newer competitors
- US-only, tied to US insurance and regulatory requirements
Techcyte
- Regulatory status runs the opposite way to what most buyers assume: the products are CE marked and clinically deployed in Europe while several United States offerings including Fusion Parasitology are labelled research use only and not for diagnostic use, so an American laboratory must verify each module individually.
- Slide scanning for parasitology, haematology and cytology needs multi plane imaging that a histology scanner may not produce, so a laboratory that already owns a scanner often has to buy new hardware, which becomes the biggest line in the project.
- Each discipline is licensed separately, so a laboratory wanting parasitology, urinalysis and haematology assembles three modules and three validation studies rather than buying one platform.
- AI pre screening does not remove the need for a qualified reviewer to release results, so the staffing saving is in review time per slide, not in headcount, and business cases that assume otherwise do not hold.
- Techcyte covers a very wide set of disciplines, which means depth varies between them, and the maturity of a newer module is not the maturity of the parasitology or cytology products that made the company its name.
Pricing, plan by plan
Rx30
On request- Rx30$undefined/month
- Prescription processing
- Claims adjudication
- Inventory
Techcyte
On request- Techcyte$undefined/year
- Priced per slide or per annual specimen volume by discipline
- Each discipline module licensed separately
- Slide scanning hardware bought separately, not included
Which should you pick?
Choose Rx30 if
- You need prescription processing.
- You work on Windows, Web.
- You also want claims adjudication.
Choose Techcyte if
- You need fusion parasitology suite.
- You also want cervical cytology.
Questions people ask
- Is Rx30 or Techcyte better?
- Neither clearly leads. Rx30 starts at On request and Techcyte at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, Rx30 or Techcyte?
- Rx30 starts at On request and Techcyte at On request.
- Does Rx30 or Techcyte run on more platforms?
- Rx30 runs on Windows, Web. Techcyte runs on Web.
- What is Rx30 best used for?
- Rx30 is most often used for independent pharmacies and small chains wanting a mature, widely-supported system, operations relying on a broad set of wholesaler and pbm interfaces, pharmacies with significant front-end retail alongside dispensing, multi-store independents needing consistency across locations. Of those, independent pharmacies and small chains wanting a mature, widely-supported system and operations relying on a broad set of wholesaler and pbm interfaces are not what Techcyte is typically brought in for.
- What can Rx30 do that Techcyte cannot?
- Rx30 covers Prescription processing, Claims adjudication, Inventory and purchasing, Point of sale. Techcyte covers Fusion Parasitology Suite, Cervical cytology, Haematology, Urinalysis.
Answered from the vendors’ own pages
Rx30: Is Rx30 the same company as PioneerRx?
Both are owned by RedSail Technologies. They are sold as separate products to overlapping markets, but roadmap decisions sit with one company, which is worth knowing before treating them as independent options.
Techcyte: Is Techcyte FDA cleared?
Not uniformly. Several United States offerings, including the Fusion Parasitology Suite, are labelled research use only and not for diagnostic use in the United States. Check the regulatory status of each specific module for your country before purchase.
Rx30: What does it cost?
Not published. Request the total including hardware, interfaces and training rather than the monthly software fee.
Techcyte: Can we use it clinically in Europe?
Techcyte solutions are CE marked and clinically deployed across Europe, which is where its regulatory position is strongest. Confirm the current certificate for the specific module.
Rx30: Why do pharmacies stay on it?
Installed base maturity. The interfaces to wholesalers, PBMs and hardware are long established, and those are the things that quietly stop a pharmacy working when they break.
Techcyte: Does it eliminate the need for a technologist?
No. AI pre screens and prioritises, but a qualified reviewer still releases results. The saving is in review time per slide.
Rx30: How does it compare to PioneerRx?
PioneerRx is more aggressively developed around clinical services. Rx30 has the larger legacy base and broader front-end retail heritage. Same owner, different emphasis.
Techcyte: Do we need a specific scanner?
Techcyte works with several scanner vendors, but disciplines such as parasitology and haematology need multi plane imaging that many histology scanners cannot produce, so confirm hardware compatibility early.
Rx30: Is it suitable for a small chain?
Yes, and that is one of its stronger cases. Multi-store consistency is better handled here than by the systems aimed purely at single independents.
Related pages
Other head to heads
- Rx30 vs Liberty Software
- Rx30 vs BestRx
- Rx30 vs Epic Systems
- Rx30 vs Cerner
- Rx30 vs Dentrix
- Rx30 vs Zocdoc
- Rx30 vs eClinicalWorks
- Rx30 vs GoodRx
- Rx30 vs Ro
- Rx30 vs SilverCloud by Amwell
- Rx30 vs OpenClinica
- Rx30 vs Therapixel
- Rx30 vs Bahmni
- Rx30 vs Beckman Coulter DxONE
- Rx30 vs Carestream Dental
- Rx30 vs ChiroTouch
- Rx30 vs Cerner PowerChart
- Rx30 vs Cerner PowerWorks
- Rx30 vs PathAI
- Rx30 vs Lunit
- Rx30 vs Ibex Medical Analytics
- Rx30 vs Sysmex
- Rx30 vs Paige
- Rx30 vs Sectra
- Rx30 vs Gleamer
- Rx30 vs Annalise.ai
- Rx30 vs Koa Health
- Rx30 vs Fullscript
- Rx30 vs Doctolib
- Rx30 vs Doximity
- Rx30 vs eClinicalWorks Prime
- Techcyte vs Liberty Software
- Techcyte vs BestRx
- Techcyte vs Epic Systems
- Techcyte vs Cerner
- Techcyte vs Dentrix
- Techcyte vs Zocdoc
- Techcyte vs eClinicalWorks
- Techcyte vs GoodRx
- Techcyte vs Ro
- Techcyte vs SilverCloud by Amwell
- Techcyte vs OpenClinica
- Techcyte vs Therapixel
- Techcyte vs Bahmni
- Techcyte vs Beckman Coulter DxONE
- Techcyte vs Carestream Dental
- Techcyte vs ChiroTouch
- Techcyte vs Cerner PowerChart
- Techcyte vs Cerner PowerWorks
- Techcyte vs PathAI
- Techcyte vs Lunit
- Techcyte vs Ibex Medical Analytics
- Techcyte vs Sysmex
- Techcyte vs Paige
- Techcyte vs Sectra
- Techcyte vs Gleamer
- Techcyte vs Annalise.ai
- Techcyte vs Koa Health
- Techcyte vs Fullscript
- Techcyte vs Doctolib
- Techcyte vs Doximity
- Techcyte vs eClinicalWorks Prime
